Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 373 (miR-373) is a small, noncoding RNA of approximately 22 nucleotides that regulates gene expression post-transcriptionally by either repressing translation or degrading target mRNAs. It was initially identified as an embryonic stem cell-specific microRNA and has been extensively studied for its roles in both promoting and suppressing tumorigenesis, depending on tissue and molecular context. miR-373 participates in regulating the cell cycle, proliferation, apoptosis, migration, and invasion, and has been implicated as a therapeutic target and biomarker in several types of cancer, such as non-small cell lung cancer, hepatocellular carcinoma, cervical cancer, and testicular germ cell tumors. It can modulate gene expression via conventional mRNA targeting as well as by inducing promoter-driven transcription in select situations.
Gene expression modulation by mRNA degradation or translational repression, Induction of gene expression by promoter targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 373 (miR-373).